Lactobacillus acidophilus MAK32L61A and Reduced Plasma Cholesterol Levels

• Lactobacillus acidophilus ATCC 4356 Prevents Atherosclerosis via Inhibition of Intestinal Cholesterol Absorption in Apolipoprotein E-Knockout Mice

  • 2014-12-15
  • Clinical Trial
  • Applied and Environmental Microbiology 80(24)
  • • Ying Huang
    • Jinfeng Wang
    • Guihua Quan
    • Xiaojun Wang
    • Longfei Yang
    • Lili Zhong

  • PubMed: 25261526
  • DOI: 10.1128/AEM.02926-14

  3 Insights on

  • Reduced Plasma Cholesterol Levels

  • Low evidence
  • Highly Cited
  • Animal Study
  • Clinical

  L. acidophilus ATCC 4356 protected ApoE(-/-) mice from atherosclerosis by reducing their plasma cholesterol levels from 923 ± 44 to 581 ± 18 mg/dl.

  Effect

  Beneficial

  Effect size

  Large